Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Hutter

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Investigation|October 21, 2014
BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemiaNiuscha Yaktapour, Frank Meiss, Justin Mastroianni, et al.
Nature Communications|February 7, 2020
Genomic footprints of activated telomere maintenance mechanisms in cancerLina Sieverling, Chen Hong, Sandra D Koser, et al.
Epigenetics & Chromatin|November 12, 2018
Integrative analysis of single-cell expression data reveals distinct regulatory states in bidirectional promotersFatemeh Behjati Ardakani, Kathrin Kattler, Karl Nordström, et al.
International Journal of Cancer|September 19, 2020
Integrating proteomics into precision oncologyLeonie W Wahjudi, Stephan Bernhardt, Khalid Abnaof, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2022
Comprehensive molecular profiling of sarcomas in adolescent and young adult patients: Results of the EORTC SPECTA-AYA international proof-of-concept studyMarie Morfouace, Peter Horak, Simon Kreutzfeldt, et al.
Cold Spring Harbor Molecular Case Studies|December 1, 2016
Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with <i>PDL1</i> amplificationStefan Gröschel, Martin Bommer, Barbara Hutter, et al.
Cold Spring Harbor Molecular Case Studies|March 6, 2019
Response to olaparib in a <i>PALB2</i> germline mutated prostate cancer and genetic events associated with resistancePeter Horak, Joachim Weischenfeldt, Gunhild von Amsberg, et al.
Oncogene|September 28, 2019
Identification and characterization of a BRAF fusion oncoprotein with retained autoinhibitory domainsFlorian Weinberg, Ricarda Griffin, Martina Fröhlich, et al.
Leukemia|March 5, 2020
Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemiaPeter Horak, Sebastian Uhrig, Maximilian Witzel, et al.
Nature Communications|October 8, 2020
Framework for quality assessment of whole genome cancer sequencesJustin P Whalley, Ivo Buchhalter, Esther Rheinbay, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Investigation|October 21, 2014
BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemiaNiuscha Yaktapour, Frank Meiss, Justin Mastroianni, et al.
Nature Communications|February 7, 2020
Genomic footprints of activated telomere maintenance mechanisms in cancerLina Sieverling, Chen Hong, Sandra D Koser, et al.
Epigenetics & Chromatin|November 12, 2018
Integrative analysis of single-cell expression data reveals distinct regulatory states in bidirectional promotersFatemeh Behjati Ardakani, Kathrin Kattler, Karl Nordström, et al.
International Journal of Cancer|September 19, 2020
Integrating proteomics into precision oncologyLeonie W Wahjudi, Stephan Bernhardt, Khalid Abnaof, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2022
Comprehensive molecular profiling of sarcomas in adolescent and young adult patients: Results of the EORTC SPECTA-AYA international proof-of-concept studyMarie Morfouace, Peter Horak, Simon Kreutzfeldt, et al.
Cold Spring Harbor Molecular Case Studies|December 1, 2016
Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with <i>PDL1</i> amplificationStefan Gröschel, Martin Bommer, Barbara Hutter, et al.
Cold Spring Harbor Molecular Case Studies|March 6, 2019
Response to olaparib in a <i>PALB2</i> germline mutated prostate cancer and genetic events associated with resistancePeter Horak, Joachim Weischenfeldt, Gunhild von Amsberg, et al.
Oncogene|September 28, 2019
Identification and characterization of a BRAF fusion oncoprotein with retained autoinhibitory domainsFlorian Weinberg, Ricarda Griffin, Martina Fröhlich, et al.
Leukemia|March 5, 2020
Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemiaPeter Horak, Sebastian Uhrig, Maximilian Witzel, et al.
Nature Communications|October 8, 2020
Framework for quality assessment of whole genome cancer sequencesJustin P Whalley, Ivo Buchhalter, Esther Rheinbay, et al.
Pageof 7